Egerton Capital (UK) LLP: CRS position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Egerton Capital (UK) LLP on CRS, newest first. How the timeline and the estimate are built.
Egerton Capital (UK) LLP held 0 CRS shares at 2026-06-30 per its 13F-HR filed 2026-07-21.
the latest 13F is the newest step
- period ended2026-06-3013F 0 sharesChange vs previous 13F -1,330,920 shares
13F-HR 0001581811-26-000007 filed by Egerton Capital (UK) LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2026-03-3113F 1,330,920 sharesChange vs previous 13F -222,092 shares
5.82% of the 13F portfolio, value $524,582,118.
13F-HR 0001581811-26-000005 filed by Egerton Capital (UK) LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 1,553,012 sharesChange vs previous 13F +178,679 shares
5.31% of the 13F portfolio, value $488,950,298.
13F-HR 0001581811-26-000002 filed by Egerton Capital (UK) LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 1,374,333 sharesChange vs previous 13F -534,734 shares
3.56% of the 13F portfolio, value $337,453,725.
13F-HR 0001581811-25-000010 filed by Egerton Capital (UK) LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 1,909,067 sharesChange vs previous 13F +89,182 shares
5.41% of the 13F portfolio, value $527,627,937.
13F-HR 0001581811-25-000007 filed by Egerton Capital (UK) LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 1,819,885 sharesChange vs previous 13F not available
3.8% of the 13F portfolio, value $329,726,764.
13F-HR 0001581811-25-000005 filed by Egerton Capital (UK) LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).